Shares in Subiaco-based Singular Health rose up to 17.5 cents a share on Thursday, following a landmark deal with Roseman University of Health Sciences in the US.
Shares in Subiaco-based Singular Health rose up to 17.5 cents a share on Thursday, following a landmark deal with Roseman University of Health Sciences in the US.
Singular closed trade at 15 cents a share, up 59 per cent, after opening the day at 9.6 cents per share.
The company told the market it had entered in a two-year deal with Roseman, a private institution which, under the binding purchase order, will accquire 50 3Dicom R&D licences and 5,000 3Dicom patient licences for approximately $152,000.
With accquistion of the 3Dicom R&D licences, Roseman's Henderson campus, located 15 minutes from downtown Las Vegas, will become the first US college to adopt Singular's 3Dicom R&D software for medical education purposes.
Long term, the medical education software market is predicted to be worth $US17.6 billion, or $A26.9 billion, by 2027.
Following purchase orders from the Majmaah University in Saudi Arabia last December, Singular began work on deploying non-diagnostic artificial intelligence models into its 3Dicom R&D software.
This allows users to selectively view and manipulate individual body parts or anatomical systems through real patient scans instead of stylised, interactive 3D anatomical models.
Roseman has two campuses in the state of Nevada and one in Utah. The university's flagship Henderson campus in Nevada is located 10 minutes from the Harry Reid International Airport, a hub for Southwest Airlines.
